Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UltraEZ and Enamelast for Dentin Hypersensitivity
NCT03076944Unknown
- Sponsor
- Universidade Federal de Uberlândia
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial of UltraEZ and sodium fluoride in dentin hypersensitivity (DH) (3 arms), sponsored by Universidade Federal de Uberlândia. Primary endpoint: Visual Analog Scale at 24 weeks. Status: unknown.
02
Drugs
UltraEZsodium fluoride
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT03076944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03076944.